Noncontiguous Stage II Adult Burkitt Lymphoma Terminated Phase 2 Trials for Allopurinol (DB00437)

IndicationStatusPhase
DBCOND0029301 (Noncontiguous Stage II Adult Burkitt Lymphoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01564277Rasburicase and Allopurinol in Treating Patients With Hematologic MalignanciesTreatment